Demand for access to real-time production data is promoting the adoption of digital bioprocessing technology in the pharmaceutical subcontracting sector, particularly by contract development and manufacturing organisations (CDMOs), says Rob Perry, senior director of manufacturing engineering for Thermo Fisher’s Pharma Services sector. Benefits include reduced paperwork, productivity improvements, increased manufacturing visibility and capacity expansion. Regulators, though working to keep pace with technological developments, present a challenge. Staff training on augmented and virtual reality tools and facilities’ virtual tours are also proving cost-effective.
Open source leaders are pushing for permanent government financing to maintain open source projects. They argue that as government oversight is vital to the national